Literature DB >> 2459408

Molecular basis for cytolytic T-lymphocyte recognition of the murine cytomegalovirus immediate-early protein pp89.

M Del Val1, H Volkmer, J B Rothbard, S Jonjić, M Messerle, J Schickedanz, M J Reddehase, U H Koszinowski.   

Abstract

The murine cytomegalovirus protein pp89, which is encoded by gene ieI, is a nonstructural regulatory protein expressed in the immediate-early phase of the viral replication cycle and located mainly in the nucleus of infected cells. Protection of BALB/c (H-2d) mice against a lethal murine cytomegalovirus challenge infection is achieved by vaccination with a recombinant vaccinia virus, MCMV-ieI-VAC, expressing pp89 as the only murine cytomegalovirus gene product. The protection is entirely mediated by T lymphocytes of the CD8+ subset. In the present report, we analyzed the molecular basis of the recognition of pp89 by BALB/c CD8+ cytolytic T lymphocytes. A series of internal and terminal deletion mutants of gene ieI was constructed and cloned in vaccinia virus, and the antigenicity and immunogenicity of the fragments of pp89 expressed by the recombinants were studied. A region of only one-sixth of the protein, from amino acids 154 to 249 and encoded by the fourth exon of gene ieI, was sufficient for both the recognition in vitro of the protein by pp89-specific cytotoxic T lymphocytes and the induction in vivo of pp89-specific cytotoxic T lymphocytes. By using synthetic peptides, the sequence between residues 161 and 179, which is located within the defined domain, was identified as an epitope presented to BALB/C cytotoxic T lymphocytes by the class I major histocompatibility antigen Ld.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2459408      PMCID: PMC253823     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents.

Authors:  S Avrameas; T Ternynck
Journal:  Immunochemistry       Date:  1969-01

2.  Cytomegalovirus: pathogenicity, immunity, and vaccine initiatives.

Authors:  J E Osborn
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

3.  Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients.

Authors:  G V Quinnan; N Kirmani; A H Rook; J F Manischewitz; L Jackson; G Moreschi; G W Santos; R Saral; W H Burns
Journal:  N Engl J Med       Date:  1982-07-01       Impact factor: 91.245

4.  Temporal regulation of murine cytomegalovirus transcription and mapping of viral RNA synthesized at immediate early times after infection.

Authors:  G M Keil; A Ebeling-Keil; U H Koszinowski
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

5.  The cytolytic T lymphocyte response to the murine cytomegalovirus. II. Detection of virus replication stage-specific antigens by separate populations of in vivo active cytolytic T lymphocyte precursors.

Authors:  M J Reddehase; G M Keil; U H Koszinowski
Journal:  Eur J Immunol       Date:  1984-01       Impact factor: 5.532

6.  pEMBL: a new family of single stranded plasmids.

Authors:  L Dente; G Cesareni; R Cortese
Journal:  Nucleic Acids Res       Date:  1983-03-25       Impact factor: 16.971

7.  Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant.

Authors:  J D Meyers; N Flournoy; E D Thomas
Journal:  J Infect Dis       Date:  1980-12       Impact factor: 5.226

8.  Molecular cloning and physical mapping of murine cytomegalovirus DNA.

Authors:  A Ebeling; G M Keil; E Knust; U H Koszinowski
Journal:  J Virol       Date:  1983-09       Impact factor: 5.103

9.  A sequence pattern common to T cell epitopes.

Authors:  J B Rothbard; W R Taylor
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

10.  Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing.

Authors:  R Shimonkevitz; J Kappler; P Marrack; H Grey
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

View more
  41 in total

1.  Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope.

Authors:  M Del Val; H J Schlicht; H Volkmer; M Messerle; M J Reddehase; U H Koszinowski
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

Review 2.  Molecular anatomy of viral persistence.

Authors:  M B Oldstone
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

3.  Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides.

Authors:  T Hanke; F L Graham; K L Rosenthal; D C Johnson
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

4.  A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface.

Authors:  M F Kleijnen; J B Huppa; P Lucin; S Mukherjee; H Farrell; A E Campbell; U H Koszinowski; A B Hill; H L Ploegh
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

5.  Focal transcriptional activity of murine cytomegalovirus during latency in the lungs.

Authors:  S K Kurz; M Rapp; H P Steffens; N K Grzimek; S Schmalz; M J Reddehase
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

6.  Control of murine cytomegalovirus in the lungs: relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates.

Authors:  R Holtappels; J Podlech; G Geginat; H P Steffens; D Thomas; M J Reddehase
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

7.  Memory T cells persisting in the brain following MCMV infection induce long-term microglial activation via interferon-γ.

Authors:  Manohar B Mutnal; Shuxian Hu; Morgan R Little; James R Lokensgard
Journal:  J Neurovirol       Date:  2011-07-29       Impact factor: 2.643

8.  Concerted antigen processing of a short viral antigen by human caspase-5 and -10.

Authors:  Daniel López; Mercedes Jiménez; Margarita García-Calvo; Margarita Del Val
Journal:  J Biol Chem       Date:  2011-03-28       Impact factor: 5.157

9.  Antiviral prevention of sepsis induced cytomegalovirus reactivation in immunocompetent mice.

Authors:  Meghan R Forster; Joanne Trgovcich; Peter Zimmerman; Alexander Chang; Cortland Miller; Paul Klenerman; Charles H Cook
Journal:  Antiviral Res       Date:  2009-12-11       Impact factor: 5.970

10.  Efficient expression of tum- antigen P91A by transfected subgenic fragments.

Authors:  P Chomez; E De Plaen; A Van Pel; C De Smet; J P Szikora; C Lurquin; A M Lebacq-Verheyden; T Boon
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.